Skip to content

A clinical trail to study the effects of alpha blocker tamsulosin and drug combination alpha blocker tamsulosin and competitive muscarinic-receptor antagonist solifenacin in treatment with ureteral stent related lower urinary tract symptoms.

Effects of tamsulosin and tamsulosin + solifenacin combination therapy in treatment of ureteral stent related lower urinary tract symptoms.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024945
Enrollment
100
Registered
2020-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

None listed

Sponsors

ankit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing Double-J stenting for ureteral intervention were included in the study.

Exclusion criteria

Exclusion criteria: 1-Patients who were previously diagnosed with benign prostatic hyperplasia or overactive bladder. 2-Pregnant women. 3- Psychiatric illness 4-Urinary tract infections. 5-Previous use of selective alpha-1- blocker and or antimuscarinic agent or with known history of orthostatic hypotension,allergy,hypersensitivity to one or more alpha blockers. 6-Patients under ICU management 7-Patients on dialysis.

Design outcomes

Primary

MeasureTime frame
1. International Prostate Symptom Score/quality of life 2.visual analogue pain scaleTimepoint: 1. On the day of PER URETHRAL CATHETER REMOVAL 2.On the day of DJ stent removal

Secondary

MeasureTime frame
1. STORAGE SYMPTOMS IMPROVEMENT 2. VOIDING SYMPTOMS IMPROVEMENTTimepoint: 1. on the day of per urethral catheter Removal 2. on the day of DJ stent removal

Countries

India

Contacts

Public ContactD SREEDHAR

dr.Pinnameneni shiddharta institute of medical science and research foundation

sreedh2003@gmail.com9177618303

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 14, 2026